Cargando…
The FATIGUE-PRO: a new patient-reported outcome instrument to quantify fatigue in patients affected by systemic lupus erythematosus
OBJECTIVES: This study aimed to implement a patient-centred and evidence-based approach to develop a novel patient-reported outcome (PRO) instrument to measure fatigue in patients with SLE. METHODS: A three-step mixed methods psychometric (MMP) approach was followed. Steps comprised first draft item...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9348773/ https://www.ncbi.nlm.nih.gov/pubmed/34897375 http://dx.doi.org/10.1093/rheumatology/keab920 |
_version_ | 1784761987961454592 |
---|---|
author | Morel, Thomas Cano, Stefan Bartlett, Susan J Gordon, Caroline Haier, Birgit Regnault, Antoine Schneider, Matthias Stach, Christian Cleanthous, Sophie |
author_facet | Morel, Thomas Cano, Stefan Bartlett, Susan J Gordon, Caroline Haier, Birgit Regnault, Antoine Schneider, Matthias Stach, Christian Cleanthous, Sophie |
author_sort | Morel, Thomas |
collection | PubMed |
description | OBJECTIVES: This study aimed to implement a patient-centred and evidence-based approach to develop a novel patient-reported outcome (PRO) instrument to measure fatigue in patients with SLE. METHODS: A three-step mixed methods psychometric (MMP) approach was followed. Steps comprised first draft item generation and review using interview data; evaluation and refinement of second draft items using mixed methods data, including interview and quantitative data from a phase 2 clinical study in SLE analysed using Rasch Measurement Theory (RMT) analysis; and evaluation of the final FATIGUE-PRO items using RMT and complementary Classical Test Theory (CTT) analyses. Guided by MMP criteria, a team of clinicians and outcome-measurement experts assessed evidence to inform instrument development. RESULTS: Step 1 culminated in 55 items (n = 39 patients interviewed). Their refinement in step 2 using mixed methods evidence led to the final FATIGUE-PRO instrument comprising 31 items across three scales of fatigue: physical fatigue (9 items), mental and cognitive fatigue (11 items) and susceptibility to fatigue (11 items). Qualitative (n = 43 patients) and quantitative (n = 106 patients) evidence strongly supported the scales’ content comprehensiveness and targeting, item quality and fit, conceptual uniqueness and appropriateness of the response scale. The FATIGUE-PRO further benefited from excellent reliability (RMT: 0.92–0.94 and CTT: 0.95–0.96) and supportive evidence of construct validity from assessments against other PROs. CONCLUSION: The conceptual advances, comprehensive coverage and strong psychometric properties of the FATIGUE-PRO will significantly advance the measurement and management of fatigue in SLE, both in clinical trials and routine practice. TRIAL REGISTRATION: ClinicalTrials.gov (https://clinicaltrials.gov), NCT02804763 |
format | Online Article Text |
id | pubmed-9348773 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Oxford University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-93487732022-08-04 The FATIGUE-PRO: a new patient-reported outcome instrument to quantify fatigue in patients affected by systemic lupus erythematosus Morel, Thomas Cano, Stefan Bartlett, Susan J Gordon, Caroline Haier, Birgit Regnault, Antoine Schneider, Matthias Stach, Christian Cleanthous, Sophie Rheumatology (Oxford) Clinical Science OBJECTIVES: This study aimed to implement a patient-centred and evidence-based approach to develop a novel patient-reported outcome (PRO) instrument to measure fatigue in patients with SLE. METHODS: A three-step mixed methods psychometric (MMP) approach was followed. Steps comprised first draft item generation and review using interview data; evaluation and refinement of second draft items using mixed methods data, including interview and quantitative data from a phase 2 clinical study in SLE analysed using Rasch Measurement Theory (RMT) analysis; and evaluation of the final FATIGUE-PRO items using RMT and complementary Classical Test Theory (CTT) analyses. Guided by MMP criteria, a team of clinicians and outcome-measurement experts assessed evidence to inform instrument development. RESULTS: Step 1 culminated in 55 items (n = 39 patients interviewed). Their refinement in step 2 using mixed methods evidence led to the final FATIGUE-PRO instrument comprising 31 items across three scales of fatigue: physical fatigue (9 items), mental and cognitive fatigue (11 items) and susceptibility to fatigue (11 items). Qualitative (n = 43 patients) and quantitative (n = 106 patients) evidence strongly supported the scales’ content comprehensiveness and targeting, item quality and fit, conceptual uniqueness and appropriateness of the response scale. The FATIGUE-PRO further benefited from excellent reliability (RMT: 0.92–0.94 and CTT: 0.95–0.96) and supportive evidence of construct validity from assessments against other PROs. CONCLUSION: The conceptual advances, comprehensive coverage and strong psychometric properties of the FATIGUE-PRO will significantly advance the measurement and management of fatigue in SLE, both in clinical trials and routine practice. TRIAL REGISTRATION: ClinicalTrials.gov (https://clinicaltrials.gov), NCT02804763 Oxford University Press 2021-12-13 /pmc/articles/PMC9348773/ /pubmed/34897375 http://dx.doi.org/10.1093/rheumatology/keab920 Text en © The Author(s) 2021. Published by Oxford University Press on behalf of the British Society for Rheumatology. https://creativecommons.org/licenses/by-nc/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial License (https://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com |
spellingShingle | Clinical Science Morel, Thomas Cano, Stefan Bartlett, Susan J Gordon, Caroline Haier, Birgit Regnault, Antoine Schneider, Matthias Stach, Christian Cleanthous, Sophie The FATIGUE-PRO: a new patient-reported outcome instrument to quantify fatigue in patients affected by systemic lupus erythematosus |
title | The FATIGUE-PRO: a new patient-reported outcome instrument to quantify fatigue in patients affected by systemic lupus erythematosus |
title_full | The FATIGUE-PRO: a new patient-reported outcome instrument to quantify fatigue in patients affected by systemic lupus erythematosus |
title_fullStr | The FATIGUE-PRO: a new patient-reported outcome instrument to quantify fatigue in patients affected by systemic lupus erythematosus |
title_full_unstemmed | The FATIGUE-PRO: a new patient-reported outcome instrument to quantify fatigue in patients affected by systemic lupus erythematosus |
title_short | The FATIGUE-PRO: a new patient-reported outcome instrument to quantify fatigue in patients affected by systemic lupus erythematosus |
title_sort | fatigue-pro: a new patient-reported outcome instrument to quantify fatigue in patients affected by systemic lupus erythematosus |
topic | Clinical Science |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9348773/ https://www.ncbi.nlm.nih.gov/pubmed/34897375 http://dx.doi.org/10.1093/rheumatology/keab920 |
work_keys_str_mv | AT morelthomas thefatigueproanewpatientreportedoutcomeinstrumenttoquantifyfatigueinpatientsaffectedbysystemiclupuserythematosus AT canostefan thefatigueproanewpatientreportedoutcomeinstrumenttoquantifyfatigueinpatientsaffectedbysystemiclupuserythematosus AT bartlettsusanj thefatigueproanewpatientreportedoutcomeinstrumenttoquantifyfatigueinpatientsaffectedbysystemiclupuserythematosus AT gordoncaroline thefatigueproanewpatientreportedoutcomeinstrumenttoquantifyfatigueinpatientsaffectedbysystemiclupuserythematosus AT haierbirgit thefatigueproanewpatientreportedoutcomeinstrumenttoquantifyfatigueinpatientsaffectedbysystemiclupuserythematosus AT regnaultantoine thefatigueproanewpatientreportedoutcomeinstrumenttoquantifyfatigueinpatientsaffectedbysystemiclupuserythematosus AT schneidermatthias thefatigueproanewpatientreportedoutcomeinstrumenttoquantifyfatigueinpatientsaffectedbysystemiclupuserythematosus AT stachchristian thefatigueproanewpatientreportedoutcomeinstrumenttoquantifyfatigueinpatientsaffectedbysystemiclupuserythematosus AT cleanthoussophie thefatigueproanewpatientreportedoutcomeinstrumenttoquantifyfatigueinpatientsaffectedbysystemiclupuserythematosus AT morelthomas fatigueproanewpatientreportedoutcomeinstrumenttoquantifyfatigueinpatientsaffectedbysystemiclupuserythematosus AT canostefan fatigueproanewpatientreportedoutcomeinstrumenttoquantifyfatigueinpatientsaffectedbysystemiclupuserythematosus AT bartlettsusanj fatigueproanewpatientreportedoutcomeinstrumenttoquantifyfatigueinpatientsaffectedbysystemiclupuserythematosus AT gordoncaroline fatigueproanewpatientreportedoutcomeinstrumenttoquantifyfatigueinpatientsaffectedbysystemiclupuserythematosus AT haierbirgit fatigueproanewpatientreportedoutcomeinstrumenttoquantifyfatigueinpatientsaffectedbysystemiclupuserythematosus AT regnaultantoine fatigueproanewpatientreportedoutcomeinstrumenttoquantifyfatigueinpatientsaffectedbysystemiclupuserythematosus AT schneidermatthias fatigueproanewpatientreportedoutcomeinstrumenttoquantifyfatigueinpatientsaffectedbysystemiclupuserythematosus AT stachchristian fatigueproanewpatientreportedoutcomeinstrumenttoquantifyfatigueinpatientsaffectedbysystemiclupuserythematosus AT cleanthoussophie fatigueproanewpatientreportedoutcomeinstrumenttoquantifyfatigueinpatientsaffectedbysystemiclupuserythematosus |